EQAS - Home - ALCAD di Alessio Chiga - servizi informatici … · · 2017-04-05External Quality...

Customer Information

Lab: 000673

Attn: DR. LORENZO LEONEDR PASQUALE PIGNATELLIVIA MARTIRI D’’OTRANTO 2LECCE (LE) 73100ITALY

Copyright 2016 Bio−Rad Laboratories, Inc. All rights reserved. EQAS is a trademark of Bio−Rad Laboratories, Inc.

Page 1 of 50

¹ Expanded uncertainty coverage factor, k=2Printed on recyclable paper 16 Dec 2016

Exceptions

EQAS News

External Quality Assurance Services

EQASImmunoassay (Monthly) Program (BC75)

Cycle 13: December 2015 − December 2016Sample No: 12 Sample Date: 12 Dec 16

IMPORTANT: Place your order for the next cycle now by contacting your Bio−Rad Representative.

Bio−Rad Laboratories is accredited to ISO/IEC 17043:2010.Refer to the User Guide for additional information on the EQAS Program,EQAS reports, their interpretation, statistics, and contact details.

Analyte Instrument Result Unit Z−score Comparator✍ 17−a−OH−Progesterone Cisbio Bioassays

✍ 25−OH−Vitamin D (Total) DiaSorin LIAISON/XL

✍ ACTH DiaSorin LIAISON/XL

✍ AFP Siemens ADVIA Centaur Systems

✍ Aldosterone Cisbio Bioassays

✍ B−2−Microglobulin DiaSorin LIAISON/XL

✍ C−Peptide Siemens ADVIA Centaur Systems

✍ CA 125 Siemens ADVIA Centaur Systems

✍ CA 15−3 Siemens ADVIA Centaur Systems

✍ CA 19−9 Siemens ADVIA Centaur Systems

✍ Carbamazepine Siemens ADVIA Centaur Systems

✍ CEA Siemens ADVIA Centaur Systems

✍ Cortisol Siemens ADVIA Centaur Systems

✍ DHEA−Sulfate Beckman Coulter Access, LXi 725, DxC 600i IA Systems

✍ Digoxin Siemens ADVIA Centaur Systems

✍ Estradiol (E2) Roche Elecsys / cobas e 411 Series

✍ Estriol, Free (UE3) Siemens IMMULITE 2000/2500/XPi

✍ Ferritin Siemens Dimension Vista

✍ Folate Siemens ADVIA Centaur Systems

Legend: ✔ No Warnings ✍ Missing Result ¦ Late Results 2,0 < |Z−score| < 3,0 ✘ |Z−score| > 3,0 * Amended Result (per participant’s request)

Copyright 2016 Bio−Rad Laboratories, Inc. All rights reserved. EQAS is a trademark of Bio−Rad Laboratories, Inc.

Page 2 of 50


Exceptions


EQASImmunoassay (Monthly) Program (BC75)

Cycle 13: December 2015 − December 2016Sample No: 12 Sample Date: 12 Dec 16

Analyte Instrument Result Unit Z−score Comparator✍ FSH Roche Elecsys / cobas e 411 Series

✍ Gastrin Siemens IMMULITE/1000

✍ Growth Hormone Siemens IMMULITE/1000

✍ hCG Beckman Coulter Access, LXi 725, DxC 600i IA Systems

✍ IgE Phadia ImmunoCAP Series

✍ Insulin Siemens ADVIA Centaur Systems

✍ Luteinizing Hormone Roche Elecsys / cobas e 411 Series

✍ Phenobarbital Siemens ADVIA Centaur Systems

✍ Phenytoin Siemens ADVIA Centaur Systems

✍ Progesterone Roche Elecsys / cobas e 411 Series

✍ Prolactin Roche Elecsys / cobas e 411 Series

✍ PSA, Free Beckman Coulter Access, LXi 725, DxC 600i IA Systems

✍ PSA, Total Beckman Coulter Access, LXi 725, DxC 600i IA Systems

✍ PTH, Intact DiaSorin LIAISON/XL

✍ Renin, Direct Cisbio Bioassays

✍ SHBG Roche Elecsys / cobas e 411 Series

✍ T3, Free Siemens Dimension Vista

✍ T4, Free Siemens Dimension Vista

✍ Testosterone Siemens ADVIA Centaur Systems

✍ Theophylline Siemens ADVIA Centaur Systems

✍ TSH Siemens Dimension Vista

✍ Valproic Acid Siemens ADVIA Centaur Systems

✍ Vitamin B12 Siemens ADVIA Centaur Systems

Legend: ✔ No Warnings ✍ Missing Result ¦ Late Results 2,0 < |Z−score| < 3,0 ✘ |Z−score| > 3,0 * Amended Result (per participant’s request)


EQAS

Configuration ReportImmunoassay (Monthly) ProgramLab 000673

DR PASQUALE PIGNATELLIVIA MARTIRI D’’OTRANTO 2LECCE (LE) 73100ITALY

Cycle 13Dec 2015 − Dec 2016

Sample No: 12Sample Date: 12 Dec 16

Lot No: 231200

Copyright 2016 Bio−Rad Laboratories, Inc. All rights reserved.EQAS is a trademark of Bio−Rad Laboratories, Inc. Page 3 of 50


Selected Options:Data Input: Online

Report Receipt: QCNet

Subgroup Number: None

Instrument 2555 − Beckman Coulter Access 2

Analyte Method Reagent Unit251 DHEAS 063 Chemiluminescence 0006 Dedicated Reagent 63 µg/L

223 FPSA 063 Chemiluminescence 0707 Beckman Coulter PSA, Hybritech Calibration 02 ng/mL

028 HCG 063 Chemiluminescence 0959 hCG, WHO 5th International Std 07/364 34 mIU/mL

343 PSA 063 Chemiluminescence 0707 Beckman Coulter PSA, Hybritech Calibration 02 ng/mL

Instrument 0443 − Cisbio Bioassays

Analyte Method Reagent Unit396 17HP 038 RIA 0006 Dedicated Reagent 63 µg/L

008 ALDO 038 RIA 0006 Dedicated Reagent 01 pg/mL

643 REND 038 RIA 0006 Dedicated Reagent 01 pg/mL

Instrument 2260 − DiaSorin LIAISON

Analyte Method Reagent Unit600 25VD 063 Chemiluminescence 0006 Dedicated Reagent 02 ng/mL

205 ACTH 063 Chemiluminescence 0006 Dedicated Reagent 01 pg/mL

224 B2MG 063 Chemiluminescence 0006 Dedicated Reagent 64 mg/L

345 IPTH 063 Chemiluminescence 0542 Diasorin LIAISON 1−84 PTH (REF 310630) 01 pg/mL

Instrument 1257 − Phadia ImmunoCAP 250

Analyte Method Reagent Unit299 IGE 072 FIA 0006 Dedicated Reagent 77 kIU/L

Instrument 1180 − Roche cobas e 411

Analyte Method Reagent Unit261 E2 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 01 pg/mL

073 FSH 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 34 mIU/mL

112 LH 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 34 mIU/mL

340 PROG 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 02 ng/mL

341 PROL 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 33 µIU/mL

549 SHBG 619 Electrochemiluminescence (ECL) 0006 Dedicated Reagent 52 nmol/L

Instrument 1183 − Siemens ADVIA Centaur XP

Analyte Method Reagent Unit


EQAS

Configuration ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Instrument Cont.1183 − Siemens ADVIA Centaur XP

Analyte Method Reagent Unit206 AFP 063 Chemiluminescence 0006 Dedicated Reagent 63 µg/L

191 B12 063 Chemiluminescence 0006 Dedicated Reagent 01 pg/mL

231 C125 063 Chemiluminescence 0006 Dedicated Reagent 59 kU/L

229 C15−3 063 Chemiluminescence 0006 Dedicated Reagent 59 kU/L

230 C19−9 063 Chemiluminescence 0006 Dedicated Reagent 59 kU/L

234 CARB 063 Chemiluminescence 0006 Dedicated Reagent 03 µg/mL

236 CEA 063 Chemiluminescence 0006 Dedicated Reagent 02 ng/mL

041 CORT 063 Chemiluminescence 0006 Dedicated Reagent 13 µg/dL

428 CPEP 063 Chemiluminescence 0006 Dedicated Reagent 02 ng/mL

053 DIG 063 Chemiluminescence 0006 Dedicated Reagent 63 µg/L

070 FOL 063 Chemiluminescence 0006 Dedicated Reagent 02 ng/mL

103 INS 063 Chemiluminescence 0006 Dedicated Reagent 33 µIU/mL

132 PHEN 063 Chemiluminescence 0006 Dedicated Reagent 03 µg/mL

133 PHYT 063 Chemiluminescence 0006 Dedicated Reagent 03 µg/mL

167 TEST 063 Chemiluminescence 0006 Dedicated Reagent 63 µg/L

169 THEO 063 Chemiluminescence 0006 Dedicated Reagent 03 µg/mL

388 VALP 063 Chemiluminescence 0006 Dedicated Reagent 03 µg/mL

Instrument 0940 − Siemens Dimension Vista

Analyte Method Reagent Unit067 FERR 063 Chemiluminescence 0006 Dedicated Reagent 02 ng/mL

179 FT3 063 Chemiluminescence 0006 Dedicated Reagent 01 pg/mL

183 FT4 063 Chemiluminescence 0006 Dedicated Reagent 12 ng/dL

177 TSH 063 Chemiluminescence 0006 Dedicated Reagent 74 mIU/L

Instrument 1535 − Siemens IMMULITE 2000/XPi

Analyte Method Reagent Unit263 UE3 063 Chemiluminescence 0006 Dedicated Reagent 02 ng/mL

Instrument 1193 − Siemens IMMULITE/1000

Analyte Method Reagent Unit278 GAST 063 Chemiluminescence 0006 Dedicated Reagent 01 pg/mL

491 HGH 063 Chemiluminescence 0006 Dedicated Reagent 02 ng/mL


EQAS

Sample Summary ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Analyte Unit Result Mean Z−score RMZ Comparator✍ DHEA−Sulfate

✍ hCG

✍ PSA, Free

✍ PSA, Total

Instrument: Beckman Coulter Access, LXi 725, DxC 600i IA Systems

Analyte Unit Result Mean Z−score RMZ Comparator✍ 17−a−OH−Progesterone

✍ Aldosterone

✍ Renin, Direct

Instrument: Cisbio Bioassays

Analyte Unit Result Mean Z−score RMZ Comparator✍ 25−OH−Vitamin D (Total)

✍ ACTH

✍ B−2−Microglobulin

✍ PTH, Intact

Instrument: DiaSorin LIAISON/XL

Analyte Unit Result Mean Z−score RMZ Comparator✍ IgE

Instrument: Phadia ImmunoCAP Series

Analyte Unit Result Mean Z−score RMZ Comparator✍ Estradiol (E2)

✍ FSH

✍ Luteinizing Hormone

✍ Progesterone

✍ Prolactin

✍ SHBG

Instrument: Roche Elecsys / cobas e 411 Series

Analyte Unit Result Mean Z−score RMZ Comparator✍ AFP

Instrument: Siemens ADVIA Centaur Systems

Legend: ✔ No Warnings ✍ Missing Result ¦ Late Results 2,0 < |Z−score| < 3,0 ✘ |Z−score| > 3,0

* Amended Result (per participant’s request) ³ Non−robust determination of Mean and SD

Problem Classification:

Corrective Action:

Reviewed by: Date:


EQAS

Sample Summary ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Analyte Unit Result Mean Z−score RMZ Comparator✍ C−Peptide

✍ CA 125

✍ CA 15−3

✍ CA 19−9

✍ Carbamazepine

✍ CEA

✍ Cortisol

✍ Digoxin

✍ Folate

✍ Insulin

✍ Phenobarbital

✍ Phenytoin

✍ Testosterone

✍ Theophylline

✍ Valproic Acid

✍ Vitamin B12

Instrument: Siemens ADVIA Centaur Systems

Analyte Unit Result Mean Z−score RMZ Comparator✍ Ferritin

✍ T3, Free

✍ T4, Free

✍ TSH

Instrument: Siemens Dimension Vista

Analyte Unit Result Mean Z−score RMZ Comparator✍ Estriol, Free (UE3)

Instrument: Siemens IMMULITE 2000/2500/XPi

Analyte Unit Result Mean Z−score RMZ Comparator✍ Gastrin

✍ Growth Hormone

Instrument: Siemens IMMULITE/1000

Legend: ✔ No Warnings ✍ Missing Result ¦ Late Results 2,0 < |Z−score| < 3,0 ✘ |Z−score| > 3,0

* Amended Result (per participant’s request) ³ Non−robust determination of Mean and SD

Problem Classification:

Corrective Action:

Reviewed by: Date:


EQAS

DHEA−Sulfate ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Beckman Coulter Access, LXi 725, DxC ...

Your Result

− µg/L

Comparative Statistics Your Deviation

��¢©®²

N Mean SD CV U¹ Z−score RMZ %

Your Mode 215 3613 276 7,65 47,1

Your Method 328 3916 534 13,6 73,8 No comparison possible

Your Peer 9 3708 189 5,10 158

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date

Jan−16 Feb−16 Mar−16 Apr−16 May−16 Jun−16 Jul−16 Aug−16 Sep−16 Oct−16 Nov−16 Dec−16

11

1,2

08

1,8

14

10,2

11

19,0

09

1,8

13

19,6

11

1,3

08

1,8

12 10 14 12

®²

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

1,2 10,2 19,0

®²

��

��

��

PEER

9,03 10,96

2

METHOD

3,38 17,88

49

MODE

6,06 13,55

38

N Mean CV U¹

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Dedicated Reagent

121 4890 4,74 52,7

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceDedicated Reagent

118 4410 4,56 46,3

Roche Elecsys / cobas e 411 SeriesElectrochemiluminescence (ECL)Dedicated Reagent

94 4947 5,65 72,1

Siemens IMMULITE 2000/2500/XPiChemiluminescenceDedicated Reagent

76 3562 7,51 76,7

Siemens ADVIA Centaur SystemsChemiluminescenceDedicated Reagent

48 3567 8,00 103

Beckman Coulter UniCel DxI SeriesChemiluminescenceDedicated Reagent

38 3649 8,34 123

Siemens IMMULITE/1000ChemiluminescenceDedicated Reagent

18 3709 4,69 102

Roche MODULAR (ISE, D, P, E170)Electrochemiluminescence (ECL)Dedicated Reagent

18 4955 5,66 165

DiaSorin LIAISON/XLChemiluminescenceDedicated Reagent

10 3756 5,28 157

DH

EA

−Sulfa

te 1

3:

CYC

LE

12

SA

MP

LE


EQAS

hCG ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− mIU/mL


��¢©®²


Your Mode 299 3432 449 13,1 64,9


Your Peer 19 2856 337 11,8 193

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

9,0

08

12,4

14

3048

11

5939

09

12,2

13

5887

11

8,8

08

12,1

12 10 14 12

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

8,8 3048 5887

��

��

��

��

PEER

2100 3357

3

METHOD

673,7 4098

205

MODE

1187 5676

49

N Mean CV U¹


363 2141 4,15 11,7


186 2308 8,29 35,1


179 2419 5,09 23,0


177 2520 5,93 28,1

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche hCG + B Ref 03271749

158 2442 4,51 21,9


86 2786 7,98 59,9

Roche Elecsys / cobas e 411 SeriesElectrochemiluminescence (ECL)Roche hCG + B Ref 03271749

82 2467 6,13 41,7

Siemens IMMULITE 2000/XPiChemiluminescenceDedicated Reagent

67 3182 12,5 121

Beckman Coulter Access, LXi 725, Dx...ChemiluminescenceDedicated Reagent

64 2889 11,5 104

hC

G 1

3:

CYC

LE

12

SA

MP

LE


EQAS

PSA, Free ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− ng/mL


��¢©®²


Your Mode 152 2,29 0,154 6,70 0,031

Your Method 588 1,69 0,147 8,72 0,015 No comparison possible

Your Peer 13 2,27 0,185 8,12 0,128

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

1,7

08

2,3

14

2,5

11

2,5

09

2,4

13

2,5

11

1,8

08

2,3

12 10 14 12

®²

®²��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

1,7 1,8 2,3 2,5

®²

��

®²

��

��

��

��

PEER

1,35 2,59

2

METHOD

1,12 2,42

93

MODE

1,53 2,68

16

N Mean CV U¹


249 1,67 4,59 0,012


238 1,70 3,75 0,010


122 1,61 4,90 0,018


109 1,73 6,28 0,026

Beckman Coulter UniCel DxI SeriesChemiluminescenceBeckman Coulter PSA, Hybritech Calibration

39 2,33 5,55 0,052


31 2,27 8,58 0,087


29 1,44 7,97 0,053

bioMérieux VIDAS GroupFIADedicated Reagent

25 2,28 5,57 0,063


24 1,70 4,40 0,038

PSA

, Fre

e 1

3:

CYC

LE

12

SA

MP

LE


EQAS

PSA, Total ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− ng/mL


��¢©®²


All Results 1756 11,7 1,000 8,55 0,060


Your Peer 19 13,2 0,658 4,98 0,377

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

3,5

08

5,1

14

13,1

11

23,1

09

5,2

13

22,9

11

3,7

08

5,1

12 10 14 12

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

3,5 13,1 22,9

��

��

��

��

��

��

��

PEER

9,91 14,70

3

METHOD

4,95 17,60

143

ALL RESULTS

6,69 16,69

291

N Mean CV U¹


385 11,6 5,12 0,075


335 11,9 3,76 0,061


263 12,2 5,25 0,099


243 10,2 5,38 0,088

Beckman Coulter UniCel DxI SeriesChemiluminescenceBeckman Coulter PSA, Hybritech Calibration

46 13,1 5,89 0,283

Siemens ADVIA Centaur CPChemiluminescenceDedicated Reagent

43 10,0 7,21 0,276

VITROS Microwell SeriesChemiluminescenceDedicated Reagent

43 11,9 4,60 0,209


43 12,5 7,08 0,336


38 13,2 5,86 0,314

PSA

, Tota

l 13

:C

YC

LE

12

SA

MP

LE


EQAS

17−a−OH−Progesterone ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Cisbio Bioassays

Your Result

− µg/L


��¢©®²


Your Mode 93 9,31 2,03 21,8 0,526


Your Peer 2 8,38 1,48 17,6 2,61

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

31,8

08

45,5

14

25,5

11

1,5

09

42,5

13

1,5

11

29,8

08

47,7

12 10 14 12

®²®²

®²®²

®²

®² ®²

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

1,5 25,5 29,8 42,5

®²

®² ®²®² ®²

®²

®²

PEER

22,60 28,18

1

METHOD

1,85 60,49

7

MODE

1,85 58,93

14

N Mean CV U¹

DIAsource ImmunoAssaysRIADedicated Reagent

17 10,4 15,2 0,952

DRG International, Inc.EIADedicated Reagent

17 9,77 17,7 1,05

IBL InternationalEIADedicated Reagent

14 11,9 15,3 1,22

Beckman Coulter ImmunotechRIADedicated Reagent

12 7,84 20,2 1,14

DIAsource ImmunoAssaysEIADedicated Reagent

5 10,6 16,9 1,99

Monobind AccuBindEIADedicated Reagent

4 8,74 16,6 1,82

MP BiomedicalsRIADedicated Reagent

3 8,60 19,0 2,36

Cisbio BioassaysRIADedicated Reagent

2 8,38 17,6 2,61

ManualEIADedicated Reagent

2 6,92 23,5 2,88

17

−a−O

H−P

rogeste

rone 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Aldosterone ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Cisbio Bioassays

Your Result

− pg/mL


��¢©®²


Your Mode 87 326 40,8 12,5 10,9


Your Peer 3 336 23,0 6,85 33,2

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

113

08

202

14

332

11

513

09

155

13

497

11

112

08

153

12 10 14 12

¢©

¢© ®²

®²

®²

®² ®²

®²

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

112 153 202 332 497

®²

¢©

®²®²

¢© ®²®²

®²

PEER

303,5 353,3

1

METHOD

50,70 579,1

3

MODE

122,1 447,0

13

N Mean CV U¹


52 322 9,64 10,8

IDS iSYSChemiluminescenceDedicated Reagent

5 378 6,49 27,5


3 336 6,85 33,2


3 304 26,2 115

ZenTechRIADedicated Reagent

3 254 38,2 140

DSL ACTIVERIADedicated Reagent

3 552 0,942 7,51

Diagnostics BiochemEIADedicated Reagent

3 400 13,7 78,8

IBL InternationalEIADedicated Reagent

3 334 7,24 34,9

ManualRIADedicated Reagent

2 319 46,4 262

Ald

oste

rone 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Renin, Direct ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Cisbio Bioassays

Your Result

− pg/mL


��¢©®²


All Results 75 119 16,8 14,1 4,84

Your Method 11 105 3,98 3,78 3,00 No comparison possible

Your Peer 6 105 1,89 1,80 1,93

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

33,0

08

41,8

14

106

11

169

09

40,5

13

174

11

30,9

08

41,7

12 10 14 12

®² ¢©

¢©¢©

¢©

¢©

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

30,9 106 169

¢©

®²

¢©

¢©

¢©¢©

PEER

95,56 106,8

2

METHOD

85,50 125,3

2

ALL RESULTS

34,79 160,6

8

N Mean CV U¹


54 121 12,7 5,24


6 105 1,80 1,93

IDS iSYSChemiluminescenceDedicated Reagent

5 123 10,9 15,0


2 122 18,3 39,4


1 102 0 0


1 83,4 0 0

DSL ACTIVERIADedicated Reagent

1 113 0 0


1 139 0 0

Autobio DiagnosticsChemiluminescenceDedicated Reagent

1 74,0 0 0

Renin

, Dire

ct 1

3:

CYC

LE

12

SA

MP

LE


EQAS

25−OH−Vitamin D (Total) ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



DiaSorin LIAISON/XL

Your Result

− ng/mL


��¢©®²


Your Mode 973 23,4 3,29 14,1 0,264


Your Peer 62 27,2 3,03 11,2 0,963

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

23,1

08

24,5

14

28,7

11

32,3

09

24,9

13

32,1

11

22,1

08

24,4

12 10 14 12

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

22,1 23,1 24,4 28,7 32,1

��

��

��

��

PEER

20,10 37,90

9

METHOD

12,32 45,26

91

MODE

6,96 39,85

158

N Mean CV U¹


168 22,1 5,75 0,245


146 21,1 13,1 0,571


144 27,1 12,0 0,676


112 22,4 10,5 0,554


62 27,2 11,2 0,963


50 32,7 11,2 1,30


38 21,5 14,0 1,22


36 26,6 6,19 0,685


35 24,5 13,5 1,40

25

−O

H−Vita

min

D (T

ota

l) 13

:C

YC

LE

12

SA

MP

LE


EQAS

ACTH ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



DiaSorin LIAISON/XL

Your Result

− pg/mL


��¢©®²


Your Mode 139 84,8 23,4 27,6 4,96


Your Peer 20 106 63,8 60,2 35,6

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

18,0

08

58,8

14

88,3

11

189

09

57,3

13

133

11

19,0

08

51,3

12 10 14 12

®²��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

18,0 51,3 88,3 133 189

®²��

��

��

��

��

PEER

11,19 198,0

2

METHOD

11,19 201,5

19

MODE

11,19 198,0

23

N Mean CV U¹


87 86,2 21,0 4,84


51 50,5 52,3 9,25


46 54,4 47,8 9,58


20 106 60,2 35,6


19 69,4 33,2 13,2


6 52,0 67,5 35,9

Tosoh AIA ModelsEIADedicated Reagent

4 83,0 79,8 82,8


3 141 19,1 39,0

BRAHMS RIARIADedicated Reagent

3 97,7 51,9 73,2

AC

TH

13

:C

YC

LE

12

SA

MP

LE


EQAS

B−2−Microglobulin ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



DiaSorin LIAISON/XL

Your Result

− mg/L


��¢©®²


All Results 215 3,23 0,273 8,45 0,046


Your Peer 14 2,96 0,351 11,8 0,234

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

1,2

08

1,3

14

3,0

11

4,5

09

1,3

13

4,8

11

0,9

08

1,3

12 10 14 12

¢©

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

0,9 3,0 4,5

��

¢©

��

��

��

��

PEER

2,31 4,33

3

METHOD

2,16 4,72

10

ALL RESULTS

1,86 4,59

35

N Mean CV U¹


46 3,07 8,86 0,100

Roche cobas 6000/8000/c 311ImmunoturbidimetricDedicated Reagent

45 3,22 4,91 0,059


25 3,33 7,44 0,124

Abbott AEROSET/ARCHITECT (c, i, ci ...ImmunoturbidimetricDedicated Reagent

14 3,32 2,70 0,060


14 2,96 11,8 0,234


11 3,40 12,0 0,307

Siemens BN Series NephelometersImmunonephelometric, fixed time, kineticDedicated Reagent

8 3,19 5,22 0,147

Siemens BN Series NephelometersImmunonephelometric, end pointDedicated Reagent

6 3,42 3,43 0,120

Beckman Coulter AU 400/480/600/640/...ImmunoturbidimetricDedicated Reagent

5 3,45 3,26 0,126

B−2

−M

icro

glo

bulin

13

:C

YC

LE

12

SA

MP

LE


EQAS

PTH, Intact ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



DiaSorin LIAISON/XL

Your Result

− pg/mL


��¢©®²


Your Mode 30 44,8 4,34 9,70 1,98


Your Peer 6 45,2 4,25 9,41 4,34

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

56,9

08

74,1

14

44,3

11

6,6

09

76,6

13

6,6

11

60,8

08

81,7

12 10 14 12

®²®²

®² ®²

®²

®² ®²

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

6,6 44,3 56,9 74,1

®²

®²

®²

®²®² ®² ®²

PEER

25,50 50,20

1

METHOD

9,20 285,4

62

MODE

25,50 66,51

7

N Mean CV U¹


115 85,8 5,54 1,11


112 91,7 6,22 1,35


92 110 10,5 3,02


91 148 9,82 3,80

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCH iPTH, (Routine mode, assay file 581)

47 146 8,61 4,58

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche ECL PTH, REF 11972103

46 86,6 6,31 2,01


42 128 7,50 3,72


40 78,4 8,48 2,63

Beckman Coulter UniCel DxI SeriesChemiluminescenceBeckman Coulter Access PTH − (Routine)

30 75,5 8,27 2,85

PTH

, Inta

ct 1

3:

CYC

LE

12

SA

MP

LE


EQAS

IgE ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Phadia ImmunoCAP Series

Your Result

− kIU/L


��¢©®²


Your Mode 737 276 25,5 9,24 2,35


Your Peer 10 252 20,7 8,20 16,3

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

319

08

440

14

254

11

81,8

09

430

13

84,5

11

306

08

432

12 10 14 12

¢© ��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

81,8 254 306 430

��

��

��

��

¢©

��

��

PEER

152,0 289,0

2

METHOD

152,0 376,0

7

MODE

148,6 403,8

112

N Mean CV U¹


154 290 3,60 2,11


148 291 5,71 3,42


105 262 4,48 2,86


58 281 9,39 8,67


43 261 6,66 6,63


40 266 10,9 11,5


33 243 11,4 12,1


18 261 3,26 5,01

Tosoh AIA ModelsEIADedicated Reagent

16 275 6,11 10,5

IgE

13

:C

YC

LE

12

SA

MP

LE


EQAS

Estradiol (E2) ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Roche Elecsys / cobas e 411 Series

Your Result

− pg/mL


��¢©®²


Your Mode 1296 219 23,2 10,6 1,61


Your Peer 151 214 15,9 7,42 3,23

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

45,3

08

56,2

14

223

11

450

09

55,9

13

448

11

45,1

08

56,0

12 10 14 12

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

45,1 223 448

��

��

��

��

��

PEER

134,4 293,2

30

METHOD

157,3 278,9

81

MODE

103,1 335,2

203

N Mean CV U¹


270 197 3,94 1,18


170 231 5,03 2,23


151 214 7,42 3,23


138 217 4,97 2,30

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche ECL Estradiol III (06656021)

115 220 4,10 2,10


88 253 13,4 9,07


72 242 5,25 3,73


41 214 7,28 6,08


35 262 10,2 11,3

Estra

dio

l (E2) 1

3:

CYC

LE

12

SA

MP

LE


EQAS

FSH ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− mIU/mL


��¢©®²


Your Mode 1562 21,4 2,38 11,1 0,151


Your Peer 221 22,1 1,09 4,94 0,184

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

5,1

08

7,0

14

22,5

11

39,8

09

7,0

13

39,6

11

5,1

08

6,9

12 10 14 12

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

5,1 22,5 39,6

��

��

��

PEER

16,64 27,56

34

METHOD

15,74 27,20

83

MODE

9,52 33,35

242

N Mean CV U¹


291 21,1 4,18 0,130


283 19,8 5,00 0,147


221 22,1 4,94 0,184


171 25,2 5,40 0,260


107 18,8 6,77 0,307

Siemens ADVIA Centaur SystemsChemiluminescenceSiemens Centaur/XP FSH, Cal B Lot 41+

96 25,1 6,31 0,403


69 23,1 6,90 0,480


60 17,9 8,91 0,515


53 21,8 6,72 0,503

FSH

13

:C

YC

LE

12

SA

MP

LE


EQAS

Luteinizing Hormone ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− mIU/mL


��¢©®²


Your Mode 1004 22,4 1,60 7,14 0,126


Your Peer 217 22,9 1,21 5,27 0,205

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

2,8

08

3,8

14

22,6

11

42,1

09

3,9

13

42,4

11

2,9

08

3,9

12 10 14 12

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

2,8 22,6 42,1

��

��

��

��

��

PEER

16,86 27,17

29

METHOD

17,38 27,17

75

MODE

14,37 30,34

142

N Mean CV U¹


285 22,9 4,52 0,153


283 21,1 6,41 0,201


255 16,7 6,70 0,175


217 22,9 5,27 0,205


104 17,9 7,72 0,338


67 18,5 7,01 0,396


59 18,8 8,80 0,540


53 21,4 6,10 0,449

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCHITECT LH (2P40)

49 16,8 6,71 0,402

Lute

iniz

ing H

orm

one 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Progesterone ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− ng/mL


��¢©®²


Your Mode 1127 8,38 1,04 12,5 0,078


Your Peer 135 8,96 0,446 4,98 0,096

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

14,2

08

17,7

14

9,2

11

1,9

09

17,7

13

1,9

11

14,1

08

17,7

12 10 14 12

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

1,9 9,2 14,1 17,7

��

��

��

PEER

7,28 10,94

21

METHOD

6,62 11,15

75

MODE

3,16 13,60

173

N Mean CV U¹


228 8,07 6,32 0,084


214 7,18 7,75 0,095


135 8,96 4,98 0,096


129 8,85 4,72 0,092


87 9,51 7,47 0,190

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche ECL Progesterone III, Ref 07092539

75 8,81 4,35 0,111


55 11,6 9,21 0,360


41 7,03 6,98 0,191

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche ECL Progesterone II, REF 12145383

39 8,93 5,21 0,186

Pro

geste

rone 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Prolactin ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− µIU/mL


��¢©®²


Your Mode 571 748 39,2 5,24 4,10


Your Peer 225 765 45,8 5,99 7,63

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

13,9

08

19,9

14

35,0

11

52,7

09

20,2

13

53,3

11

14,2

08

20,4

12 10 14 12

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

13,9 19,9 35,0 52,7

��

��

��

��

��

PEER

25,29 46,89

33

METHOD

26,09 44,46

79

MODE

26,03 44,53

82

N Mean CV U¹


276 739 3,99 4,44


275 469 5,68 4,02


225 765 5,99 7,63


149 564 5,91 6,82

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCH Prol 7K76, Cal Lot 24903U100+

108 555 5,87 7,84


101 472 4,83 5,66


66 483 6,99 10,4


63 487 6,45 9,91

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCH Prol 7K76, Before Cal Lot 24903U100

52 555 5,93 11,4

Pro

lactin

13

:C

YC

LE

12

SA

MP

LE


EQAS

SHBG ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− nmol/L


��¢©®²


Your Mode 239 43,7 3,05 6,99 0,494


Your Peer 32 43,3 2,77 6,38 1,22

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

29,5

08

42,0

14

43,3

11

44,3

09

43,1

13

45,8

11

30,1

08

43,6

12 10 14 12

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

29,5 42,0 45,8

��

��

��

��

��

PEER

33,75 47,76

6

METHOD

33,75 55,55

15

MODE

28,41 58,94

36

N Mean CV U¹


55 43,6 5,17 0,759


48 42,8 7,79 1,20


46 45,8 8,10 1,37


32 43,3 6,38 1,22


14 44,0 4,58 1,35


13 41,7 5,60 1,62


10 62,1 1,99 0,975


10 43,8 4,71 1,63


2 43,2 0,557 0,425

SH

BG

13

:C

YC

LE

12

SA

MP

LE


EQAS

AFP ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Siemens ADVIA Centaur Systems

Your Result

− µg/L


��¢©®²


Your Mode 1271 200 19,3 9,67 1,35


Your Peer 156 180 11,1 6,19 2,23

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

11,6

08

15,5

14

184

11

40,2

09

15,5

13

39,7

11

11,4

08

15,3

12 10 14 12

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

11,4 39,7 184

��

��

��

��

��

��

��

PEER

124,0 235,2

23

METHOD

115,7 264,9

120

MODE

103,1 295,9

197

N Mean CV U¹


257 212 4,71 1,56


156 180 6,19 2,23


155 194 3,87 1,51


146 217 7,45 3,34


80 183 6,59 3,37

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCHITECT AFP (3P36)

76 197 3,76 2,12


68 198 7,50 4,50

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCHITECT AFP (7K67)

64 194 3,77 2,29


61 212 8,72 5,93

AFP

13

:C

YC

LE

12

SA

MP

LE


EQAS

C−Peptide ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− ng/mL


��¢©®²


Your Mode 189 6,12 0,637 10,4 0,116


Your Peer 47 5,38 0,532 9,90 0,194

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

0,7

08

1,0

14

1,8

11

2,6

09

1,0

13

2,6

11

0,7

08

1,0

12 10 14 12

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

0,7 1,0 1,8 2,6

��

��

��

��

��

��

PEER

1,13 2,10

6

METHOD

1,05 3,22

33

MODE

1,05 2,61

29

N Mean CV U¹


68 6,84 3,74 0,078


59 6,37 6,09 0,126


58 6,32 7,30 0,151


57 6,92 4,73 0,108


47 5,38 9,90 0,194


10 6,50 9,85 0,506


10 7,89 11,8 0,737


8 6,85 8,49 0,514

Roche Elecsys / cobas e 411 SeriesChemiluminescenceDedicated Reagent

4 6,77 2,24 0,189

C−P

eptid

e 1

3:

CYC

LE

12

SA

MP

LE


EQAS

CA 125 ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− kU/L


��¢©®²


Your Mode 271 63,1 3,92 6,22 0,596


Your Peer 186 63,6 3,89 6,12 0,712

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

27,3

08

37,0

14

63,4

11

85,6

09

37,1

13

86,1

11

27,6

08

37,2

12 10 14 12

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

27,3 37,0 63,4 85,6

��

��

��

��

��

��

PEER

44,12 82,99

30

METHOD

26,17 111,2

104

MODE

43,46 82,68

48

N Mean CV U¹


278 71,6 6,80 0,730


268 53,5 4,26 0,348


186 63,6 6,12 0,712


180 53,7 5,87 0,588


78 77,1 5,56 1,21


75 51,7 6,01 0,897


36 61,5 4,01 1,03


35 78,6 7,38 2,45


25 63,6 5,40 1,72

CA

125 1

3:

CYC

LE

12

SA

MP

LE


EQAS

CA 15−3 ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− kU/L


��¢©®²


Your Mode 847 240 22,6 9,39 1,94


Your Peer 127 229 24,5 10,7 5,43

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

12,5

08

18,7

14

225

11

68,0

09

19,1

13

66,7

11

13,2

08

18,8

12 10 14 12

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

12,5 66,7 225

��

��

��

��

��

PEER

106,7 310,0

18

METHOD

72,16 364,0

80

MODE

127,6 353,4

122

N Mean CV U¹


233 242 7,39 2,93


214 250 6,02 2,57


127 229 10,7 5,43


108 243 9,27 5,41


72 171 9,55 4,82


41 206 7,57 6,09


23 249 8,03 10,4


19 290 7,44 12,4


18 174 5,29 5,43

CA

15

−3 1

3:

CYC

LE

12

SA

MP

LE


EQAS

CA 19−9 ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− kU/L


��¢©®²


Your Mode 191 75,7 8,17 10,8 1,48


Your Peer 149 75,8 8,15 10,7 1,67

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

24,6

08

31,8

14

70,9

11

69,9

09

31,9

13

69,7

11

24,8

08

32,2

12 10 14 12

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

24,6 31,8 69,7

��

��

��

��

��

��

��

PEER

35,08 116,5

20

METHOD

17,71 179,1

87

MODE

34,81 116,5

28

N Mean CV U¹


245 97,8 4,98 0,778


197 102 9,52 1,74


149 75,8 10,7 1,67


145 99,1 7,36 1,51


72 89,1 6,19 1,63


60 74,1 2,76 0,660

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCH CA19−9 XR2, REF 2K91−23/28/29/38

27 104 10,5 5,26

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCH CA19−9 XR, REF 2K91−20/25/27/35

24 99,1 11,2 5,64


24 99,0 4,53 2,29

CA

19

−9 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Carbamazepine ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− µg/mL


��¢©®²


Your Mode 264 12,7 1,16 9,18 0,179


Your Peer 38 14,2 1,04 7,30 0,421

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

18,4

08

25,1

14

14,5

11

3,6

09

24,3

13

3,5

11

18,3

08

25,2

12 10 14 12

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

3,5 14,5 18,3 24,3

��

��

��

��

��

��

PEER

11,92 17,26

6

METHOD

9,60 18,00

18

MODE

7,46 18,00

39

N Mean CV U¹


47 13,2 4,74 0,228


38 14,2 7,30 0,421

Roche cobas 6000/8000/c 311KIMS (Roche)Dedicated Reagent

35 12,0 5,18 0,264


19 10,7 4,64 0,286

Roche cobas INTEGRAFluorescence Polarization−RocheDedicated Reagent

18 12,9 2,87 0,219

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCHITECT iCarb, REF 1P36−25

16 13,1 4,90 0,401


16 12,1 7,51 0,568

Roche cobas 6000/8000/c 311EIADedicated Reagent

13 12,3 7,43 0,633


8 9,30 9,06 0,744

Carb

am

azepin

e 1

3:

CYC

LE

12

SA

MP

LE


EQAS

CEA ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− ng/mL


��¢©®²


Your Mode 606 300 35,9 12,0 3,64


Your Peer 160 250 27,8 11,1 5,49

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

4,2

08

5,6

14

246

11

24,9

09

5,6

13

24,8

11

4,1

08

5,6

12 10 14 12

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

4,1 246

��

��

��

PEER

111,4 331,0

26

METHOD

125,9 475,6

116

MODE

120,2 479,1

104

N Mean CV U¹


302 321 4,66 2,15


286 232 3,52 1,20


180 239 5,65 2,51


160 250 11,1 5,49


82 290 6,87 5,50


57 300 15,1 15,0


35 346 5,31 7,77


34 300 6,23 8,03


30 299 4,14 5,65

CE

A 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Cortisol ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− µg/dL


��¢©®²


Your Mode 1052 20,5 2,33 11,4 0,180


Your Peer 126 22,7 1,58 6,96 0,351

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

6,8

08

9,3

14

22,9

11

36,8

09

9,4

13

37,6

11

6,7

08

9,3

12 10 14 12

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

6,7 22,9 36,8

��

��

��

��

��

��

��

PEER

14,77 30,53

21

METHOD

7,80 32,53

104

MODE

8,84 32,19

156

N Mean CV U¹


218 18,3 5,00 0,155


158 20,6 9,08 0,372


126 22,7 6,96 0,351


111 21,8 10,3 0,535


81 19,2 5,61 0,299

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche ECL Cortisol II (REF 06687733)

57 19,5 3,68 0,238


48 21,3 10,3 0,791


39 21,1 6,57 0,556

Siemens ADVIA Centaur SystemsChemiluminescenceSiemens Centaur (COR), Cal Lot CE 40 & above

35 23,3 7,20 0,709

Cortis

ol 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Digoxin ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− µg/L


��¢©®²


All Results 364 2,59 0,321 12,4 0,042


Your Peer 41 2,87 0,170 5,95 0,067

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

3,2

08

4,5

14

2,9

11

1,1

09

4,4

13

1,0

11

3,3

08

4,6

12 10 14 12

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

1,0 2,9 3,2 4,4

��

��

��

��

��

PEER

2,39 3,72

8

METHOD

0,880 4,03

25

ALL RESULTS

0,988 4,03

51

N Mean CV U¹


62 2,16 5,12 0,035


51 2,75 7,51 0,072


41 2,87 5,95 0,067


34 2,50 4,86 0,052


22 2,71 4,21 0,061


16 2,44 11,7 0,179


16 2,73 5,20 0,089


16 2,96 9,20 0,170


15 2,46 12,2 0,194

Dig

oxin

13

:C

YC

LE

12

SA

MP

LE


EQAS

Folate ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− ng/mL


��¢©®²


Your Mode 961 11,7 2,14 18,2 0,173


Your Peer 185 13,9 2,18 15,7 0,401

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

18,0

08

20,5

14

12,9

11

3,3

09

19,1

13

3,5

11

18,1

08

21,3

12 10 14 12

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

3,3 12,9 18,0

��

��

��

��

PEER

8,30 24,76

24

METHOD

5,80 19,43

92

MODE

3,00 22,44

132

N Mean CV U¹


229 12,5 7,78 0,161


185 13,9 15,7 0,401


144 9,42 7,42 0,146


100 10,0 12,6 0,316

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche ECL Folate III (REF 07559992)

53 9,35 5,96 0,191

Beckman Coulter UniCel DxI SeriesChemiluminescenceBeckman Coulter Access/DxI Folate (REF A98032)

51 12,5 5,10 0,224


39 12,3 5,80 0,284


38 11,4 9,81 0,452

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche ECL Folate III (REF 04476433)

33 9,74 8,65 0,367

Fola

te 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Insulin ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− µIU/mL


��¢©®²


Your Mode 126 78,1 6,31 8,08 1,41


Your Peer 105 78,4 6,66 8,50 1,62

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

17,5

08

25,1

14

78,5

11

168

09

24,7

13

170

11

17,6

08

24,2

12 10 14 12

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

17,5 78,5 168

��

��

��

��

PEER

47,10 108,9

17

METHOD

15,40 93,99

96

MODE

46,51 108,9

20

N Mean CV U¹


179 52,1 3,64 0,354


161 62,1 4,32 0,529


144 61,8 4,95 0,637


105 78,4 8,50 1,62


49 55,0 6,53 1,28


43 22,3 19,4 1,65


23 53,6 8,49 2,37


14 62,9 4,53 1,91


11 22,5 14,3 2,44

Insulin

13

:C

YC

LE

12

SA

MP

LE


EQAS

Phenobarbital ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− µg/mL


��¢©®²


All Results 165 41,4 2,47 5,97 0,480


Your Peer 11 45,8 4,47 9,76 3,37

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

55,9

08

72,4

14

45,1

11

7,8

09

75,9

13

7,7

11

55,8

08

74,6

12 10 14 12

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

7,7 45,1 55,8 72,4

��

��

��

��

��

��

PEER

40,20 53,23

3

METHOD

29,05 54,95

18

ALL RESULTS

29,03 53,71

27

N Mean CV U¹


54 41,8 5,02 0,714


27 41,0 4,32 0,853


11 45,8 9,76 3,37


9 40,4 5,98 2,01


8 40,2 1,83 0,652

Beckman Coulter UniCel DxC SeriesImmunoturbidimetricDedicated Reagent

5 37,1 7,30 3,02


5 40,5 6,46 2,92

Beckman Coulter AU 400/480/600/640/...EIADedicated Reagent

5 43,2 5,33 2,58

Siemens Dimension SeriesImmunoturbidimetricDedicated Reagent

4 43,2 5,49 2,96

Phenobarb

ital 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Phenytoin ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− µg/mL


��¢©®²


All Results 218 18,9 1,62 8,61 0,275


Your Peer 34 21,4 1,34 6,26 0,575

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

25,5

08

36,6

14

21,0

11

6,8

09

36,9

13

6,8

11

25,2

08

36,5

12 10 14 12

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

6,8 21,0 25,2 36,5

��

��

��

��

��

��

PEER

16,43 23,89

5

METHOD

11,91 29,94

18

ALL RESULTS

11,91 26,99

33

N Mean CV U¹


67 18,7 7,14 0,407


34 18,3 3,60 0,283


34 21,4 6,26 0,575


11 18,4 7,71 1,07


10 17,0 7,34 0,986


10 17,5 6,66 0,923

VITROS Microslide SeriesEIAVITROS Dry Slides Reagent Group

7 17,7 6,57 1,10

Beckman Coulter UniCel DxC SeriesImmunoturbidimetricDedicated Reagent

6 18,2 2,17 0,403

Abbott AEROSET/ARCHITECT (c, i, ci ...EIADedicated Reagent

4 17,9 3,04 0,680

Phenyto

in 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Testosterone ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− µg/L


��¢©®²


Your Mode 498 6,55 1,02 15,5 0,114


Your Peer 205 5,90 0,613 10,4 0,107

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

91,7

08

116

14

627

11

1164

09

112

13

1139

11

88,5

08

114

12 10 14 12

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

88,5 627 1139

��

��

��

��

��

��

��

PEER

283,4 896,1

33

METHOD

4,97 1666

113

MODE

146,0 1165

79

N Mean CV U¹


233 8,13 4,82 0,064


205 5,90 10,4 0,107


186 8,25 5,68 0,086


117 9,16 6,55 0,139


85 6,47 7,04 0,124

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCHITECT Testosterone, REF 2P13

65 9,15 6,72 0,191


48 7,73 6,23 0,174

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCHITECT Testosterone, REF 7K73

43 9,40 9,79 0,351


41 7,11 9,36 0,260

Testo

ste

rone 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Theophylline ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− µg/mL


��¢©®²


Your Mode 46 14,6 0,892 6,10 0,329


Your Peer 2 15,6 0,277 1,78 0,490

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

17,6

08

24,6

14

14,9

11

4,8

09

24,7

13

4,9

11

17,6

08

24,8

12 10 14 12

®²

®²

®²

®²

®²

®²®²

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

4,8 14,9 17,6 24,6

®²

®²

®²®²

®²

®²

®²

PEER

15,45 15,80

1

METHOD

13,20 15,80

2

MODE

12,60 16,90

6

N Mean CV U¹


15 14,9 3,12 0,300


10 14,1 4,48 0,498


4 15,7 3,05 0,598

VITROS Microslide SeriesEnzymetricVITROS Dry Slides Reagent Group

3 16,3 1,89 0,443

Siemens Dimension VistaImmunoturbidimetricDedicated Reagent

2 14,3 0,370 0,093


³2 13,4 0 0


2 14,0 3,44 0,850


2 15,6 1,78 0,490


2 14,1 0,571 0,142

Theophyllin

e 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Valproic Acid ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− µg/mL


��¢©®²


Your Mode 352 117 7,84 6,67 1,04


Your Peer 47 118 4,95 4,20 1,81

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

38,6

08

54,9

14

118

11

197

09

54,1

13

194

11

38,5

08

53,6

12 10 14 12

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

38,5 53,6 118 194

��

��

��

��

��

��

PEER

96,00 127,8

8

METHOD

77,39 144,1

26

MODE

78,23 156,6

49

N Mean CV U¹


101 112 6,98 1,95

Roche cobas 6000/8000/c 311EIADedicated Reagent

57 121 5,59 2,23


47 118 4,20 1,81


23 117 4,38 2,67


17 119 3,96 2,87


17 119 2,60 1,88


13 114 5,70 4,51

Siemens Dimension SeriesImmunoturbidimetricDedicated Reagent

9 117 4,94 4,80


9 120 6,42 6,43

Valp

roic

Acid

13

:C

YC

LE

12

SA

MP

LE


EQAS

Vitamin B12 ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− pg/mL


��¢©®²


All Results 1353 690 59,5 8,62 4,04


Your Peer 247 741 51,0 6,89 8,12

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

320

08

449

14

760

11

1008

09

452

13

1021

11

318

08

436

12 10 14 12

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

318 436 760 1008

��

��

��

��

��

��

��

PEER

485,7 996,1

41

METHOD

314,0 1064

118

ALL RESULTS

392,4 987,2

210

N Mean CV U¹


263 692 6,14 6,55


263 687 3,96 4,19


247 741 6,89 8,12


199 693 6,88 8,45


100 589 5,89 8,68


62 611 6,31 12,2


50 711 9,15 23,0


38 633 7,23 18,6


35 759 4,74 15,2

Vita

min

B12

13

:C

YC

LE

12

SA

MP

LE


EQAS

Ferritin ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Siemens Dimension Vista

Your Result

− ng/mL


��¢©®²


Your Mode 325 207 22,9 11,1 3,18


Your Peer 17 227 23,3 10,3 14,1

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

27,3

08

35,7

14

224

11

450

09

34,6

13

452

11

25,7

08

32,9

12 10 14 12

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

25,7 224 450

��

��

��

��

��

��

PEER

110,1 254,3

4

METHOD

15,60 527,2

93

MODE

92,08 301,4

53

N Mean CV U¹


249 296 9,47 4,44


236 268 7,55 3,29


189 367 10,4 6,91


172 265 9,50 4,79

Abbott AEROSET/ARCHITECT (c, i, ci ...ChemiluminescenceAbbott ARCHITECT Ferritin (7K59)

137 360 12,4 9,55


92 210 9,21 5,05

Roche cobas 6000/8000/c 311ImmunoturbidimetricDedicated Reagent

84 237 7,23 4,67


58 204 11,5 7,69


56 209 10,5 7,33

Ferritin

13

:C

YC

LE

12

SA

MP

LE


EQAS

T3, Free ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− pg/mL


��¢©®²


Your Mode 620 6,84 0,291 4,25 0,029


Your Peer 12 6,78 0,128 1,89 0,092

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

3,0

08

3,5

14

6,8

11

11,6

09

3,6

13

11,5

11

3,0

08

3,6

12 10 14 12

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

3,0 6,8 11,5

��

��

��

PEER

6,60 6,96

3

METHOD

2,76 8,50

146

MODE

5,38 8,29

98

N Mean CV U¹


310 6,82 3,75 0,036


289 5,97 3,33 0,029


239 5,43 4,16 0,037


213 6,84 4,67 0,055

Abbott ARCHITECT i1000/ci4100 SeriesChemiluminescenceDedicated Reagent

116 5,03 5,77 0,067


97 4,93 8,18 0,102


64 5,88 2,46 0,045


58 5,38 5,60 0,099


56 12,5 4,91 0,205

T3, F

ree 1

3:

CYC

LE

12

SA

MP

LE


EQAS

T4, Free ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− ng/dL


��¢©®²


Your Mode 645 1,85 0,204 11,1 0,020


Your Peer 19 2,09 0,073 3,47 0,042

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

0,7

08

0,8

14

2,0

11

3,8

09

0,8

13

3,8

11

0,7

08

0,8

12 10 14 12

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

0,7 2,0 3,8

��

��

��

��

��

PEER

1,99 2,45

4

METHOD

0,932 2,76

171

MODE

0,826 2,87

85

N Mean CV U¹


326 1,78 4,82 0,012


305 1,71 6,67 0,016


220 2,52 3,09 0,013


185 2,55 4,24 0,020

Roche cobas 6000/8000/c 311Electrochemiluminescence (ECL)Roche ECL FT4 II, REF 06437281

112 2,53 3,32 0,020


109 1,94 5,90 0,027


77 1,97 5,56 0,031


67 1,95 6,23 0,037

Roche Elecsys / cobas e 411 SeriesElectrochemiluminescence (ECL)Roche ECL FT4 II, REF 06437281

62 2,56 4,00 0,032

T4, F

ree 1

3:

CYC

LE

12

SA

MP

LE


EQAS

TSH ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200




Your Result

− mIU/L


��¢©®²


Your Mode 1077 18,8 2,03 10,8 0,155


Your Peer 20 21,1 0,668 3,16 0,374

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

0,4

08

0,6

14

21,2

11

45,5

09

0,6

13

45,2

11

0,4

08

0,6

12 10 14 12

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

0,4 21,2 45,2

��

��

��

��

��

PEER

19,00 23,10

4

METHOD

6,88 31,83

210

MODE

8,69 29,00

179

N Mean CV U¹


418 17,2 4,09 0,086


370 21,4 3,14 0,087


285 21,8 3,77 0,122

Siemens ADVIA Centaur SystemsChemiluminescenceSiemens Centaur TSH3−Ultra, REF 06491080

175 19,6 4,60 0,171


105 22,5 14,2 0,782


68 21,5 4,46 0,290


62 19,4 6,02 0,371

Siemens ADVIA Centaur SystemsChemiluminescenceSiemens Centaur TSH, REF 08700387

59 25,0 6,49 0,529


55 19,3 6,05 0,393

TSH

13

:C

YC

LE

12

SA

MP

LE


EQAS

Estriol, Free (UE3) ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Siemens IMMULITE 2000/2500/XPi

Your Result

− ng/mL


��¢©®²


Your Mode 95 2,23 0,232 10,4 0,060


Your Peer 31 2,14 0,198 9,28 0,089

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

0,3

08

0,4

14

2,3

11

3,6

09

0,4

13

3,7

11

0,4

08

0,4

12 10 14 12

��

��

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

0,3 2,3 3,6

��

��

��

��

��

��

��

��

PEER

1,82 2,68

3

METHOD

0,745 3,85

17

MODE

1,43 3,39

13

N Mean CV U¹


31 2,14 9,28 0,089

Siemens IMMULITE 2000/2500/XPiChemiluminescenceSiemens IMMULITE Unconjugated Estriol, UE3

28 2,27 13,0 0,139


23 2,28 10,6 0,125


13 1,04 3,33 0,024


7 0,993 3,62 0,034

Siemens IMMULITE/1000ChemiluminescenceSiemens IMMULITE Unconjugated Estriol, UE3

5 2,02 20,9 0,471

Siemens IMMULITE 2000/2500/XPiChemiluminescenceSiemens IMMULITE Unconjugated Estriol, FE3

1 2,32 0 0


1 2,61 0 0

Siemens IMMULITE/1000ChemiluminescenceSiemens IMMULITE Unconjugated Estriol, FE3

1 2,66 0 0

Estrio

l, Fre

e (U

E3

) 13

:C

YC

LE

12

SA

MP

LE


EQAS

Gastrin ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Siemens IMMULITE/1000

Your Result

− pg/mL


��¢©®²


Your Mode 50 159 28,7 18,1 10,2


Your Peer 3 139 9,36 6,73 13,5

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

318

08

382

14

155

11

21,0

09

371

13

21,0

11

309

08

383

12 10 14 12

®²®² ®²

®²

®²®²

®² ®²

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

21,0 155 309 371

®²

®²

®²®²®² ®²

®²®²

PEER

92,17 146,0

1

METHOD

28,70 210,0

6

MODE

28,70 210,0

8

N Mean CV U¹


43 159 20,1 12,2

MP BiomedicalsRIADedicated Reagent

3 172 6,20 15,4


3 108 5,41 8,43


3 139 6,73 13,5


1 159 0 0

Gastrin

13

:C

YC

LE

12

SA

MP

LE


EQAS

Growth Hormone ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Siemens IMMULITE/1000

Your Result

− ng/mL


��¢©®²


Your Mode 292 12,2 1,10 9,02 0,160


Your Peer 32 12,4 0,539 4,36 0,238

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

Means

Date


11

2,6

08

3,7

14

12,1

11

23,6

09

3,7

13

24,4

11

2,7

08

3,7

12 10 14 12

��

��

��

��

��

−3.0

−2.0

−1.0

0.0

1.0

2.0

3.0

Z−s

core

TargetMeans

2,6 12,1 23,6

��

��

��

��

��

PEER

9,67 13,40

6

METHOD

6,21 18,51

40

MODE

6,67 17,50

48

N Mean CV U¹


101 13,0 8,08 0,262


36 11,8 3,07 0,152


32 12,4 4,36 0,238


30 11,8 6,31 0,340


20 10,7 6,08 0,365


19 11,8 9,63 0,653


15 11,0 7,72 0,547

Siemens IMMULITE 2000/2500/XPiChemiluminescenceSiemens IMMULITE GRH hGH Assay (98/574)

10 12,7 6,95 0,698


5 12,3 14,1 1,93

Gro

wth

Horm

one 1

3:

CYC

LE

12

SA

MP

LE


EQAS

Data on File ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Sample Numbers

Analyte Unit¦ 1 2 3

¦ 4

¦ 5

¦ 6

¦ 7

¦ 8 9 10 11 12

DHEAS µg/L 450 700 3580 7,17 67 716 456 664 − − − −

HCG mIU/mL 8,92 12,11 3078 5946 11,94 6166 8,9 12,2 − − − −

FPSA ng/mL 1,961* 2,542* 2,53 2,604 2,2 2,48 1,66 2,24 − − − −

PSA ng/mL 4,013 5,399 14,52 25,021 4,96 22,9 3,4 5,15 − − − −

Instrument: Beckman Coulter Access 2

17HP µg/L 9,85 11,8 8,58 0,032 13 0,6 10,2 15,8 − − − −

ALDO pg/mL 59 198 320 423 208 508 113 208 − − − −

REND pg/mL 29,6 35,4 103,9 164,8 78 318 31,9 40,6 − − − −

Instrument: Cisbio Bioassays

25VD ng/mL 24,1 26,3 27,7 35,4 23 31,3 24,6 27 − − − −

ACTH pg/mL 16,92 39,07 84,9 139,3 60,2 194 18,3 59,2 − − − −

B2MG mg/L 0,908 1,286 2,905 4,59 1,36 4,44 1,18 1,33 − − − −

IPTH pg/mL 55,3 70,9 37,9 5,71 4,6 7,2 55,9 76,3 − − − −

Instrument: DiaSorin LIAISON

IGE kIU/L 302 421 244 73,6 449 84,3 326 432 − − − −

Instrument: Phadia ImmunoCAP 250

E2 pg/mL 56,23 67,15 230,2 462,5 55,76 444 46,6 58,5 − − − −

FSH mIU/mL 5,25 7,2 22,1 39,85 6,97 37,98 5,19 6,99 − − − −

LH mIU/mL 2,89 3,99 21,8 41,43 3,8 40,38 2,76 3,76 − − − −

PROG ng/mL 14,37 17,68 9,2 1,84 18 2 14,19 18,08 − − − −

PROL µIU/mL 315,4 438,7 749 1135 422,7 1125 298 418 − − − −

SHBG nmol/L 29,24 42,16 41,74 44,58 41,03 45 28,43 43,1 − − − −

Instrument: Roche cobas e 411

AFP µg/L 10,6 14,3 181,5 37,9 14,8 39,4 11,3 15,2 − − − −

CPEP ng/mL 2,73 3,89 5,92 8,93 3,2 8 2,28 3 − − − −

C125 kU/L 34 45,5 68,5 96,3 36,5 84,3 27 37,2 − − − −

C15−3 kU/L 13,1 19,6 236,4 69,9 17,8 69 12,6 17,3 − − − −

C19−9 kU/L 26,02 37,9 72,04 88,35 29,6 69,5 23,9 29,9 − − − −

CARB µg/mL 16,9 23,13 16 3,65 24,17 3,51 18,23 24,97 − − − −

CEA ng/mL 4,32 5,71 245,63 25,51 5,94 24,65 4,32 5,75 − − − −

CORT µg/dL 5,74 8,03 22,1 30,65 9,2 37 6,66 8,89 − − − −

DIG µg/L 3,61 4,84 3,08 1,23 4,6 1,06 3,5 4,8 − − − −

FOL ng/mL 18,65 20,1 13,2 3,12 19,66 3,24 17,6 19,87 − − − −

INS µIU/mL 17,46 25,13 81,2 170,9 26,16 170,7 17,9 26 − − − −

Instrument: Siemens ADVIA Centaur XP

Legend: ✔ No Warnings ¦ Late Results 2,0 < |Z−score| < 3,0 |Z−score| > 3,0 − No Result

* Amended Result (per participant’s request)


EQAS

Data on File ReportImmunoassay (Monthly) ProgramLab 000673




Lot No: 231200



Sample Numbers

Analyte Unit¦ 1 2 3

¦ 4

¦ 5

¦ 6

¦ 7

¦ 8 9 10 11 12

PHEN µg/mL 59,77 76,41 48,86 7,1 75,03 7,9 55,7 73,4 − − − −

PHYT µg/mL 22,85 37,55 24,2 7,25 143 28,3 26 36,1 − − − −

TEST µg/L 1,07 1,53 8,13 13,63 1,11 12 0,96 1,23 − − − −

THEO µg/mL 24,25 30,1 14,2 5,8 22,6 5 17 25,1 − − − −

VALP µg/mL 40,69 54,29 113,4 204,42 53,9 194 39 54 − − − −

B12 pg/mL 358 488 7,49 1058 446 988 323 452 − − − −

Instrument: Siemens ADVIA Centaur XP

FERR ng/mL 23,7 36,9 205 390,7 36,1 453 28 36,3 − − − −

FT3 pg/mL 3 3,65 2 10,72 5,3 14,6 3,2 3,6 − − − −

FT4 ng/dL 0,75 0,8 7,3 3,88 1,01 4,67 0,73 0,86 − − − −

TSH mIU/L 0,44 0,6 22,5 47,3 0,62 44,3 0,41 0,64 − − − −

Instrument: Siemens Dimension Vista

UE3 ng/mL 0,31 0,34 1,7 3 0,4 3,4 0,3 0,4 − − − −

HGH ng/mL − − − − − − − − − − − −

Instrument: Siemens IMMULITE 2000/XPi

GAST pg/mL 318 431 168 26 380 19 318 382 − − − −

HGH ng/mL 2,5 ¦ 3,4 12,5 23,2 3,8 24 2,6 3,8 − − − −

Instrument: Siemens IMMULITE/1000

Legend: ✔ No Warnings ¦ Late Results 2,0 < |Z−score| < 3,0 |Z−score| > 3,0 − No Result

* Amended Result (per participant’s request)

Date post:	17-Apr-2018
Category:	Documents
Upload:	duongduong
View:	219 times
Download:	1 times

EQAS - Home - ALCAD di Alessio Chiga - servizi informatici … · · 2017-04-05External Quality...

Documents